MapLight Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MPLT and other ETFs, options, and stocks.About MPLT
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP.
CEOChristopher A. Kroeger
CEOChristopher A. Kroeger
Employees—
Employees—
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2018
Founded2018
Employees—
Employees—
MPLT Key Statistics
Market cap848.02M
Market cap848.02M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume190.39K
Average volume190.39K
High today$19.67
High today$19.67
Low today$17.00
Low today$17.00
Open price$17.17
Open price$17.17
Volume343.86K
Volume343.86K
52 Week high$21.55
52 Week high$21.55
52 Week low$12.24
52 Week low$12.24
Stock Snapshot
The current MapLight Therapeutics(MPLT) stock price is $18.58, with a market capitalization of 848.02M.
As of 2026-01-23, MapLight Therapeutics(MPLT) stock has fluctuated between $17.00 and $19.67. The current price stands at $18.58, placing the stock +9.3% above today's low and -5.5% off the high.
The MapLight Therapeutics(MPLT)'s current trading volume is 343.86K, compared to an average daily volume of 190.39K.
In the last year, MapLight Therapeutics(MPLT) shares hit a 52-week high of $21.55 and a 52-week low of $12.24.
In the last year, MapLight Therapeutics(MPLT) shares hit a 52-week high of $21.55 and a 52-week low of $12.24.
People also own
Based on the portfolios of people who own MPLT. This list is generated using Robinhood data, and it’s not a recommendation.